273 related articles for article (PubMed ID: 18312903)
1. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
[TBL] [Abstract][Full Text] [Related]
2. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
[No Abstract] [Full Text] [Related]
3. Traditional and novel approaches to management of heart failure: successes and failures.
Anand IS; Florea VG
Cardiol Clin; 2008 Feb; 26(1):59-72, vi. PubMed ID: 18312906
[TBL] [Abstract][Full Text] [Related]
4. Management of diastolic heart failure.
le Jemtel TH; Talreja A
Rev Cardiovasc Med; 2004; 5 Suppl 4():S37-44. PubMed ID: 15627918
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF).
Hori M; Kitabatake A; Tsutsui H; Okamoto H; Shirato K; Nagai R; Izumi T; Yokoyama H; Yasumura Y; Ishida Y; Matsuzaki M; Oki T; Sekiya M;
J Card Fail; 2005 Sep; 11(7):542-7. PubMed ID: 16198251
[TBL] [Abstract][Full Text] [Related]
6. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
7. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
Hiestand B; Abraham WT
Rev Cardiovasc Med; 2005; 6 Suppl 2():S4-11. PubMed ID: 15891699
[TBL] [Abstract][Full Text] [Related]
8. Diastolic heart failure: state of the science on best treatment practices.
Reddersen LA; Keen C; Nasir L; Berry D
J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
[TBL] [Abstract][Full Text] [Related]
9. [Hyperkalemia, heart failure and reduced renal function].
Bugge JF
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1354-5. PubMed ID: 20596118
[No Abstract] [Full Text] [Related]
10. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
O'Connor CM; Arumugham P
Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of heart failure and preserved systolic function].
Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
[No Abstract] [Full Text] [Related]
12. [Pharmacological therapy of chronic heart failure in the elderly].
Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
[TBL] [Abstract][Full Text] [Related]
13. Acute decompensated heart failure: best evidence and current practice.
Mehta R; Feldman D
Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
[TBL] [Abstract][Full Text] [Related]
14. [Hypotension associated with heart failure].
Fujita H
Nihon Rinsho; 2007 May; 65 Suppl 5():375-82. PubMed ID: 17571409
[No Abstract] [Full Text] [Related]
15. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
16. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M
Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic management of heart failure caused by systolic dysfunction.
Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM
Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861
[TBL] [Abstract][Full Text] [Related]
19. Neurohormonal antagonism in heart failure: what is the optimal strategy?
Sackner-Bernstein JD; Hart D
Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
[TBL] [Abstract][Full Text] [Related]
20. The HF epidemic: the need for new treatment strategies.
Carson PE
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
